ATCT-08THE IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA: A SECONDARY ANALYSIS OF EORTC AND NRG ONCOLOGY/RTOG

Titre

ATCT-08THE IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA: A SECONDARY ANALYSIS OF EORTC AND NRG ONCOLOGY/RTOG

Auteur

Blumenthal, Deborah T.. Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
Stupp, Roger. University of Zurich Medical Center, Zurich, Switzerland
Zhang, Peixin. NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA
Kim, Michelle M.. Unibversity of Michigan, Ann Arbor, MI, USA
Gilbert, Mark R.. National Cancer Institute (NIH), Bethesda, MD, USA
Nabors, Louis B.. University of Alabama, Birmingham, AL, USA
Mason, Warren P.. Princess Margaret Cancer Centre, Toronto, ON. Canada
van den Bent, Martin J.. Erasmus University Hospital Rotterdam, Rotterdam, The Netherlands
Hegi, Monika. Lausanne University Hospital, Lausanne, Switzerland
Golfinopoulos, Vassilis. EORTC (European Organization for Research and Treatment of Cancer), Brussels, Belgium
Erridge, Sara. University of Edinburgh, Edinburgh, UK
Perry, James. Uinversity of Toronto, Toronto, ON, Canada
Fink, Karen L.. Baylor University Medical Center, Dallas, TX, USA
Brown, Paul. MD Anderson Cancer Center, Houston, TX, USA
Corn, Ben W.. Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
Karlovits, Stephen. Drexel University College of Medicine, Philadelphia, PA, USA
Schultz, Christopher. Froedtert & The Medical College of Wisconsin, Milwaukee, WI, USA
Weller, Michael. University of Zurich Medical Center, Zurich, Switzerland
Mehta, Minesh P.. University of Maryland, Baltimore, MD, USA
Gorlia, Thierry. EORTC (European Organization for Research and Treatment of Cancer), Brussels, Belgium

Type de document

Langue

Publié dans

Autre version électronique

Classification

Identifiant OAI-PMH

Voir aussi